<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    PhaseBio Pharmaceuticals, Inc.

    PhaseBio Pharmaceuticals, Inc.

    PhaseBio is a clinical-stage biopharmaceutical company focused on the development ...

    PhaseBio is a clinical-stage biopharmaceutical ...

    Filing Type:    PU
    Jasperate, Inc.

    Jasperate, Inc.

    Jasperate, Inc. is a startup company in the truest sense. We have a strong managem...

    Jasperate, Inc. is a startup company in the tru...

    Amount Raised:    $99,400.00
    Fundraising Status:    EC
    Filing Type:    CF
    Celsion Corporation

    Celsion Corporation

    Celsion Corporation is a fully integrated biopharmaceutical company focused on dev...

    Celsion Corporation is a fully integrated bioph...

    Filing Type:    PU
    Advaxis, Inc.

    Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of ca...

    Advaxis was founded on the vision that no one s...

    Filing Type:    PU
    Soleno Therapeutics, Inc.

    Soleno Therapeutics, Inc.

    Soleno Therapeutics, Inc. (Soleno) is focused on the development and commercializa...

    Soleno Therapeutics, Inc. (Soleno) is focused o...

    Filing Type:    PU
    Moderna, Inc.

    Moderna, Inc.

    Moderna is advancing messenger RNA (mRNA) science to create a new class of transfo...

    Moderna is advancing messenger RNA (mRNA) scien...

    Filing Type:    PU
    Omeros Corporation

    Omeros Corporation

    Omeros is a commercial-stage biopharmaceutical company committed to discovering, d...

    Omeros is a commercial-stage biopharmaceutical ...

    Filing Type:    PU
    PDS Biotechnology Corporation

    PDS Biotechnology Corporation

    PDS Biotechnology has a growing pipeline of clinical-stage immunotherapies to trea...

    PDS Biotechnology has a growing pipeline of cli...

    Filing Type:    PU
    Cleveland BioLabs, Inc.

    Cleveland BioLabs, Inc.

    Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative biopharmaceutical company ...

    Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an in...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.